| Description |
1 online resource (473 p.) |
| Contents |
Intro -- Preface -- Contents -- Abbreviations -- Part I: NIV and ARF: Overview, Transmission and Physiopathology, Equipment and Technologies -- ARF Mechanical Ventilation and History in Pandemics -- Introduction -- Spanish Flu -- Polio -- Ebola -- Future Perspectives and Conclusions -- Conclusion -- References -- Hospital Organizations -- Introduction -- Organization -- Laboratory and Diagnostic Imaging Services -- Triage -- Infection Control -- Healthcare Workers -- Recent TFMCC Recommendations for Staff Organization -- Increasing ICU Bed Capacity -- Management of Respiratory Failure -- Maximize the Available Supply -- Other Potential Solutions for Mechanical Ventilator Shortages -- Conclusions -- References -- Noninvasive Ventilation in Patients with Infectious Diseases in the Emergency Room -- Introduction -- Is the NIV the First Option in Infectious Disease Patients? -- NIV during the Influenza A (H1N1) Pandemic -- NIV during the COVID-19 Pandemic -- NIV and Immunodeficient Patient -- Safety of Healthcare Professionals -- References -- Noninvasive Mechanical Ventilation After Chemical Disasters -- Introduction -- Analysis of Main Topics and Discussion -- Nerve Agents -- Vesicants -- Cyanide -- Pulmonary Agents -- Riot Control Agents -- Irritant Fume Exposure -- Role of Noninvasive Mechanical Ventilation -- Conclusion -- References -- Noninvasive Ventilation in Patients with Infectious Diseases Outside Intensive Care Unit -- Introduction -- The Necessity of Setting outside the ICU during a Pandemic -- The Negative Pressure Rooms -- Implications for Healthcare Worker -- The Use of NIV in General Ward and Sub-Intensive Unit -- Conclusion -- References -- Organization of a Noninvasive Mechanical Ventilation Unit for Immunocompromised Patients -- Introduction -- Immunocompromised Scenarios -- Contraindications of NIV |
|
Hospital Resources Required for NIV -- Personnel Responsible for NIV -- Training -- Monitoring of NIV -- Administrative Participation -- References -- Transmission of Severe Acute Respiratory Syndrome During Intubation and Mechanical Ventilation -- Introduction -- Contamination Risk During Oxygen Therapy -- Nasal Cannula and Oronasal Masks -- Nebulizers, NIV, and HFNC -- Contamination Risk During Invasive Ventilation -- Contamination Risk During ECMO -- Intubation-Related Contamination Risk -- Healthcare Workers' Protective Equipment -- Summary -- References -- The Rationale of Acute Respiratory Failure in High-Risk Infections -- Introduction -- High-Flow Nasal Oxygen (HFNC) -- Use of HFNC Combined with Prone Positioning -- Noninvasive Ventilation -- Interface -- Efficacy of NIV in Pulmonary Infections and Pandemics NIV in SARS -- NIV in Influenza A H1N1 Infection -- Tuberculosis -- COVID-19 -- Aerosol Droplet Dispersion and Infection Risk Spread with NIV -- High-Risk Infections and Healthcare Worker Protocols -- Oxygen Therapy -- Invasive Ventilation -- Conclusion -- References -- Rationale of ARF Approach in Mass Causalities -- Introduction -- Discussion: Analysis -- Conclusion -- References -- NIV-Pathophysiology-High-Risk Infection, Microbiology -- Introduction -- Discussion -- References -- Nasal High-Flow Oxygen Equipment -- Introduction -- HFNC: Accessories and Setting Up -- Temperature Setting -- Flow Rate Setting -- Oxygen Setting -- Monitoring -- Bioaerosol Dispersion and Safe Distance During HFNC in Mass Infections -- The Rationale for the Use of HFNC -- Acute Hypoxemic Respiratory Failure (AHRF) -- Acute Hypercapnic Respiratory Failure -- Chronic Airway Disease -- Avoidance of Intubation -- HFNC and Preoxygenation -- NFNC in the Post-Extubation -- Palliative Care -- HFNC Use in COVID-19 Patients -- Conclusion -- References |
|
NIV-CPAP Systems -- Introduction -- The History of NIV -- CPAP: Physiology -- Indications and Contraindications -- Equipment and Mask Interface -- Clinical Significance -- Conclusion -- References -- NIV in High-Risk Infections, Mass Casualty, and Pandemics: What Interface? -- Introduction -- General Features of NIV Interface/Interface Choice Based on Type of Ventilator -- Vented Mask -- Non-vented Mask -- NIV Interface and Potential Aerosol Production -- Requisite for Ideal NIV Interface During High-Risk Airborne Infections -- Types of Interfaces for NIV in High-Risk Infection Mass Casualties and Pandemics -- Total Face Mask or Full-Face Mask -- Helmets -- Standard Face Mask/Oronasal Mask -- Prevention and Management of Interface-Related Complications During High-Risk Airborne Infections -- Air Leaks -- Facial Skin Irritation or Pressure Sores -- Oral or Nasal Dryness -- Interface and Patient-Ventilator Asynchrony -- Conclusion -- References -- NIV: Noninvasive Ventilation via Different Face Masks/Helmets -- Introduction -- History of Helmet Interface -- Bench Studies of Helmet Interface -- Helmet Interface in Pandemics -- Severe Acute Respiratory Syndrome (SARS-CoV, 2002-2003) -- Influenza A Virus (H1N1, 2009-2010) -- Middle East Respiratory Syndrome (MERS-CoV, 2012) -- Coronavirus Disease 2019/COVID-19 (SARS-CoV-2, 2019) -- References -- Humidification and Aerosol Therapy During Non-Invasive Ventilation -- Introduction -- Physiological Concepts -- Humidification Devices -- Humidification Settings -- Factors That Effect Humidification -- Infection Control -- Pressure Ulcer -- Aerosol Delivery -- Conclusion -- Aerosol Therapy -- Introduction -- Types of Aerosol Therapy -- Factors Determining the Delivery -- Optimum Position of Device -- Device -- Ventilator Settings -- Nebulization Mode -- Humidification and Aerosol Delivery -- Conclusion |
|
Noninvasive Ventilation in Legionnaires' Disease -- Introduction -- Treatment -- NIMV in Legionnaires' Disease -- References -- NIV in Tuberculosis -- Introduction -- Tuberculosis in Intensive Care Unit -- Noninvasive Ventilation in Tuberculosis -- Infection Control in the Intensive Care Unit -- Conclusion -- References -- Infant Nasal Bubble Continuous Positive Airway Pressure (CPAP) in Resource-Limited Settings -- Introduction -- Patient Selection -- General Indications -- Other Medical Considerations -- Age Recommendations -- Equipment and Design -- Supportive Care -- Weaning or Discontinuation of Bubble CPAP -- Facility Considerations -- Conclusions -- References -- Part III: High Risk Infections in Pediatrics and Newborns -- NIV-Nasal High Flow in High-Risk Pediatric Neonatology -- Introduction -- NIV in Newborns with Respiratory Distress -- The Type of NIV Methods -- Nasal Continuous Positive Airway Pressure (NCPAP) -- Nasal Intermittent Positive Pressure Ventilation (NIPPV) -- Heated Humidified High-Flow Nasal Oxygen Therapy (HHHFNOT) -- Nasal High-Frequency Oscillator Ventilation (NHFOV) -- NIV in Newborns During a Pandemic -- Neonatal Cases in 2009 H1N1 Pandemic, 2012 SARS Outbreak, and COVID-19 Pandemic -- Conclusion -- References -- NIV-Nasal High Flow in High-Risk Pediatric Infections -- Introduction -- Mechanism of Action of HFNO Therapy -- Recommended Flow Setting and Cannula Size for HFNO Therapy in Pediatric Patients -- HFNO Versus Continuous Positive Airway Pressure (CPAP) in Pediatric Sepsis -- Safety Issues in Pediatric Patients -- Conclusion -- References -- Part IV: NIV Guidelines, Protocols and Outcome, Strategies to Control Infections in Hospitals -- Guidelines and Protocol -- Introduction -- NIV-Related Contagious Risk in Infective Diseases -- What About the Risk of Transmission of Contagious During NIRT? |
| Summary |
Explains equipment and plan organization for health systems: how and when apply NIV, Presents a critical review analysis and practical implications, and Describes rationale, methodology, clinical results of NIMV in high risk infections and mass causalities |
| Bibliography |
Includes bibliographical references |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed July 17, 2023) |
| Subject |
Artificial respiration.
|
|
Lungs -- Diseases -- Treatment
|
|
Emergency medicine.
|
|
Respiratory Tract Infections -- therapy
|
|
Acute Disease -- therapy
|
|
Mass Casualty Incidents
|
|
Noninvasive Ventilation
|
|
Respiration, Artificial
|
|
Emergency Medicine
|
|
Artificial respiration.
|
|
Respiratory infections.
|
| Form |
Electronic book
|
| Author |
Esquinas, Antonio M.
|
| ISBN |
9783031296734 |
|
3031296737 |
|
